InnovaRx Innova Health Strategies

Q82.2

Congenital cutaneous mastocytosis

Billable FY2026 2025-10-01 → 2026-09-30
Exclusions 9 never code together
Q82code
Excludes1
  • acrodermatitis enteropathica (E83.2)E83.2
  • congenital erythropoietic porphyria (E80.0)E80.0
  • pilonidal cyst or sinus (L05.-)L05.-
  • Sturge-Weber (-Dimitri) syndrome (Q85.89)Q85.89
Q82.2code
Excludes1
  • cutaneous mastocytosis NOS (D47.01)D47.01D47.01
  • diffuse cutaneous mastocytosis (with onset after newborn period) (D47.01)D47.01D47.01
  • malignant mastocytosis (C96.2-)C96.2-C96.2-
  • systemic mastocytosis (D47.02)D47.02D47.02
  • urticaria pigmentosa (non-congenital) (with onset after newborn period) (D47.01)D47.01D47.01

Excludes1 — never code together. The excluded condition and this one are mutually exclusive.

Instructional notes 3
Q82.2code
Inclusion terms
  • Congenital diffuse cutaneous mastocytosis
  • Congenital maculopapular cutaneous mastocytosis
  • Congenital urticaria pigmentosa
Index entries leading here 2
Alongside this code 8 same parent — Q82
Additional references
AHA Coding Clinic® Licence required

Official coding advice for this code. Published by the American Hospital Association. Not included in this installation.

Risk adjustment

Maps to no condition category in any loaded model.

Presence is a property of the code. Untick a model to hide it everywhere.

This code

Billable
yes
Code set
FY2026
Parent
Q82
Block
Q80-Q89
Siblings
8

Present FY2024–FY2027.